As a long term holder I can't see the SP staying at these levels if R327 does the trick with UTI's
Potential for quick results from this UTI trial convinced me to top up again today. Looking forward to the short term and long term futures with company.
How good is it to invest in a company with potential to change the health outcomes for so many people.
All IMO GLTAH
Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 29.0¢ | $4.609K | 15.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 30529 | 6 |
View Market Depth
| Last trade - 10.22am 24/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |